Search research articles
Contact Us
Filters
Showing results (261-270 of 418) with videos related to
Page
of 42
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
October 28, 2023
Clinical utility of plasma ctDNA sequencing in metastatic urothelial cancer
Clara Helal, Cédric Pobel, Arnaud Bayle, et al.
Targeted Oncology
|
November 10, 2020
Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors
Jean-Pierre Delord, Antoine Italiano, Ahmad Awada, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 7, 2016
Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumours in a real-life setting
Stéphane Bouchet, Sylvie Poulette, Karine Titier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 6, 2022
Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours: Long-term follow-up of nilotinib in TGCT
Geert Spierenburg, Peter Grimison, Christine Chevreau, et al.
The Lancet. Oncology
|
March 25, 2018
Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial
Hans Gelderblom, Claire Cropet, Christine Chevreau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2021
Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of-Concept, Phase Ib Study
Albiruni R Abdul Razak, Sebastian Bauer, Cristina Suarez, et al.
International Journal of Cancer
|
September 25, 2021
Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group
Elise Lavit, Mihaela Aldea, Sophie Piperno-Neumann, et al.
Plos One
|
September 19, 2018
EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib
Olivier Bouché, Axel Le Cesne, Maria Rios, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 15, 2021
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE
Patrick Schöffski, Michaela Kubickova, Agnieszka Wozniak, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2026
Integrating tumor volumetry and liquid biopsy: a New model to define prognosis in advanced pancreatic ductal adenocarcinoma
Victor Robic, Maxime Collin, Jules Dupont, et al.
Page
of 42
Search research articles
Search
Showing results (261-270 of 418) with videos related to
Sort By:
Page
of 42
European Journal of Cancer (Oxford, England : 1990)
|
October 28, 2023
Clinical utility of plasma ctDNA sequencing in metastatic urothelial cancer
Clara Helal, Cédric Pobel, Arnaud Bayle, et al.
Targeted Oncology
|
November 10, 2020
Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors
Jean-Pierre Delord, Antoine Italiano, Ahmad Awada, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 7, 2016
Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumours in a real-life setting
Stéphane Bouchet, Sylvie Poulette, Karine Titier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 6, 2022
Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours: Long-term follow-up of nilotinib in TGCT
Geert Spierenburg, Peter Grimison, Christine Chevreau, et al.
The Lancet. Oncology
|
March 25, 2018
Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial
Hans Gelderblom, Claire Cropet, Christine Chevreau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2021
Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of-Concept, Phase Ib Study
Albiruni R Abdul Razak, Sebastian Bauer, Cristina Suarez, et al.
International Journal of Cancer
|
September 25, 2021
Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group
Elise Lavit, Mihaela Aldea, Sophie Piperno-Neumann, et al.
Plos One
|
September 19, 2018
EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib
Olivier Bouché, Axel Le Cesne, Maria Rios, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 15, 2021
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE
Patrick Schöffski, Michaela Kubickova, Agnieszka Wozniak, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2026
Integrating tumor volumetry and liquid biopsy: a New model to define prognosis in advanced pancreatic ductal adenocarcinoma
Victor Robic, Maxime Collin, Jules Dupont, et al.
Page
of 42